An Exploratory Study to Identify Factors Associated with Recurrence of Generalized Pustular Psoriasis Flares in Adult Patients in Japan
DOI:
https://doi.org/10.2340/actadv.v106.adv-2025-0024Keywords:
Diabetes mellitus, Fever, Infections, Psoriasis, Risk factors, Symptom flare upAbstract
Generalized pustular psoriasis (GPP) is a rare, systemic inflammatory disease characterized by a heterogeneous and often unpredictable clinical course involving chronic symptoms and recurrent flares. Due to the rarity of GPP, our understanding of factors associated with flare recurrence remains unclear. Using an existing data set of adult patients with GPP in Japan, we performed univariate and multivariate analyses to investigate potential factors related to GPP flare recurrence, including patient demographics, treatment and severity of baseline flare. In total, 150 patients with a baseline flare were included in this analysis; 27.3% (n=41) experienced flare recurrence during the follow-up period (mean duration: 4.16 years). For the overall population, 56.0% of patients were male (n=84), the mean age at baseline was 55.5 years, and the mean body mass index was 24.3 kg/m2. Based on the Cox proportional hazards model, comorbid diabetes mellitus, a fever of ≥38.5°C at baseline flare, experience of flare(s) prior to baseline and certain respiratory infections were associated with a higher risk of flare recurrence, similar to previously published findings. These results could help identify patients at risk of GPP flares; however, clinically applicable prediction of GPP flares requires further research in a wider population.
Downloads
References
Ohkawara A, Yasuda H, Kobayashi H, Inaba Y, Ogawa H, Hashimoto I, et al. Generalized pustular psoriasis in Japan: Two distinct groups formed by differences in symptoms and genetic background. Acta Derm Venereol 1996; 76: 68–71. DOI: https://doi.org/10.2340/00015555766871
Barker JN, Casanova E, Choon SE, Foley P, Fujita H, Gonzalez C, et al. Global Delphi consensus on treatment goals for generalized pustular psoriasis. Br J Dermatol 2025; 192: 706–716. DOI: https://doi.org/10.1093/bjd/ljae491
Fujita H, Iwasaki R, Tsuboi S, Murashiuma Y, Akiyama M. Regional differences in the prevalence of generalized pustular psoriasis in Japan. J Dermatol 2024; 51: 380–390. DOI: https://doi.org/10.1111/1346-8138.17089
L, Choon SE, Gottlieb AB, Marrakchi S, Prinz JC, Romiti R, et al. Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management. J Eur Acad Dermatol Venereol 2023; 37: 737–752. DOI: https://doi.org/10.1111/jdv.18851
Choon SE, van de Kerkhof P, Gudjonsson JE, de la Cruz C, Barker J, Morita A, et al. International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council. JAMA Dermatol 2024; 160: 758–768. DOI: https://doi.org/10.1001/jamadermatol.2024.0915
Armstrong AW, Elston CA, Elewski BE, Ferris LK, Gottlieb AB, Lebwohl MG, et al. Generalized pustular psoriasis: A consensus statement from the National Psoriasis Foundation. J Am Acad Dermatol 2024; 90: 727–730. DOI: https://doi.org/10.1016/j.jaad.2023.09.080
Strober B, Kotowsky N, Medeiros R, Mackey RH, Harrold LR, Valdecantos WC, et al. Unmet medical needs in the treatment and management of generalized pustular psoriasis flares: evidence from a survey of corrona registry dermatologists. Dermatol Ther (Heidelb) 2021; 11: 529–541. DOI: https://doi.org/10.1007/s13555-021-00493-0
Kole LCS, Tada Y, Gerdes S, Gottlieb AB, Augustin M, Zheng M, et al. A global assessment of patient experience and quality of life in generalized pustular psoriasis: Results from interviews and online surveys. Dermatol Ther (Heidelb) 2025; 15: 3037–3053. DOI: https://doi.org/10.1007/s13555-025-01483-2
Reisner DV, Johnsson FD, Kotowsky N, Brunette S, Valdecantos W, Eyerich K. Impact of generalized pustular psoriasis from the perspective of people living with the condition: results of an online survey. Am J Clin Dermatol 2022; 23: 65–71. DOI: https://doi.org/10.1007/s40257-021-00663-y
Bhutani T, Farberg AS. Clinical and disease burden of patients with generalized pustular psoriasis: a review of real-world evidence. Dermatol Ther (Heidelb) 2024; 14: 341–360. DOI: https://doi.org/10.1007/s13555-024-01103-5
Kharawala S, Golembesky AK, Bohn RL, Esser D. The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review. Expert Rev Clin Immunol 2020; 16: 239–252. DOI: https://doi.org/10.1080/1744666X.2019.1708193
JC, Choon SE, Griffiths CEM, Merola JF, Morita A, Ashcroft DM, et al. Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature review. J Eur Acad Dermatol Venereol 2023; 37: 256–273. DOI: https://doi.org/10.1111/jdv.18720
Bellinato F, Gisondi P, Marzano AV, Piaserico S, De Simone C, Damiani G, et al. Characteristics of patients experiencing a flare of generalized pustular psoriasis: a multicenter observational study. Vaccines (Basel) 2023; 11: 740. DOI: https://doi.org/10.3390/vaccines11040740
Kara Polat A, Alpsoy E, Kalkan G, Aytekin S, Uçmak D, Yasak Güner R, et al. Sociodemographic, clinical, laboratory, treatment and prognostic characteristics of 156 generalized pustular psoriasis patients in Turkey: A multicentre case series. J Eur Acad Dermatol Venereol 2022; 36: 1256–1265. DOI: https://doi.org/10.1111/jdv.18103
Imafuku S, Satoh A, Arima H, Tsuruta N, Iwasaki R, Kimura H, et al. Quality of life of patients with pustular psoriasis is inferior to that of patients with plaque psoriasis in Japan: A multicenter study with questionnaires, the short Form-36, and other patient-reported outcomes. J Dermatol 2025; 52: 682–694. DOI: https://doi.org/10.1111/1346-8138.17629
Frysz M, Patel S, Li MOY, Griffiths CEM, Warren RB, Ashcroft DM. Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort study. Br J Dermatol 2024; 191: 529–538. DOI: https://doi.org/10.1093/bjd/ljae217
Crowley J, Golembesky AK, Kotowsky N, Gao R, Bohn RL, Garry EM, et al. Clinical characteristics and healthcare resource utilization in patients with generalized pustular psoriasis: Real-world evidence from a large claims-based dataset. J Psoriasis Psoriatic Arthritis 2021; 6: 151–158. DOI: https://doi.org/10.1177/24755303211021786
Morita A, Kotowsky N, Gao R, Shimizu R, Okubo Y. Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database. J Dermatol 2021; 48: 1463–1473. DOI: https://doi.org/10.1111/1346-8138.16022
Okubo Y, Kotowsky N, Gao R, Saito K, Morita A. Clinical characteristics and health-care resource utilization in patients with generalized pustular psoriasis using real-world evidence from the Japanese Medical Data Center database. J Dermatol 2021; 48: 1675–1687. DOI: https://doi.org/10.1111/1346-8138.16084
Choon SE, Lai NM, Mohammad NA, Nanu NM, Tey KE, Chew SF. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: Analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol 2014; 53: 676–684. DOI: https://doi.org/10.1111/ijd.12070
Choon SE, Navarini AA, Pinter A. Clinical course and characteristics of generalized pustular psoriasis. Am J Clin Dermatol 2022; 23: 21–29. DOI: https://doi.org/10.1007/s40257-021-00654-z
Zelickson BD, Muller SA. Generalized pustular psoriasis. A review of 63 cases. Arch Dermatol 1991; 127: 1339–1345. 23. Baker H, Ryan TJ. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol 1968; 80: 771–793. DOI: https://doi.org/10.1111/j.1365-2133.1968.tb11947.x
Morita A, Okubo Y, Imafuku S, Tada Y, Yamanaka K, Sugiura K, et al. Assessment of flare frequency and severity of generalized pustular psoriasis in Japanese patients: A retrospective chart review study. JEADV Clinical Practice 2023; 2: 261–272. DOI: https://doi.org/10.1002/jvc2.113
Ministry of Health Labour and Welfare. Clinical survey form for GPP. [cited 2025 April 4]. Available from: https://www. nanbyou.or.jp/wp-content/uploads/upload_files/File/037- 201704-kojin.pdf
Fujita H, Terui T, Hayama K, Akiyama M, Ikeda S, Mabuchi T, et al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP. J Dermatol 2018; 45: 1235–1270. DOI: https://doi.org/10.1111/1346-8138.14523
Ohn J, Choi YG, Yun J, Jo SJ. Identifying patients with deteriorating generalized pustular psoriasis: Development of a prediction model. J Dermatol 2022; 49: 675–681. DOI: https://doi.org/10.1111/1346-8138.16383
Frühbeck G, Gómez-Ambrosi J, Ramírez B, Mentxaka A, Rodríguez A, Becerril S, et al. Increased levels of interleukin-36 in obesity and type 2 diabetes fuel adipose tissue inflammation by inducing its own expression and release by adipocytes and macrophages. Front Immunol 2022; 13: 832185. DOI: https://doi.org/10.3389/fimmu.2022.832185
Li Y, Chen S, Zhao T, Li M. Serum IL‐36 cytokines levels in type 2 diabetes mellitus patients and their association with obesity, insulin resistance, and inflammation. J Clin Lab Anal 2021; 35: e23611. DOI: https://doi.org/10.1002/jcla.23611
Lee CC, Huang YH, Chi CC, Chung WH, Chen CB. Generalized pustular psoriasis: Immunological mechanisms, genetics, and emerging therapeutics. Trends Immunol 2025; 46: 74–89. DOI: https://doi.org/10.1016/j.it.2024.12.001
Xu Z, Liu Y, Zhang J, Cao T, Ma J, Hao J, et al. Development and validation of a prognostic model for predicting flares in generalized pustular psoriasis. J Eur Acad Dermatol Venereol 2024; 38: e599–e601. DOI: https://doi.org/10.1111/jdv.19764
Choon SE, Wright AK, Griffiths CEM, Wong KW, Tey KE, Lim YT, et al. Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a populationbased cohort study using routinely captured electronic health records in the Teleprimary Care (TPC®) clinical information system from 2010 to 2020. Br J Dermatol 2023; 189: 410–418. DOI: https://doi.org/10.1093/bjd/ljad158
Additional Files
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
